TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Chiesi Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
565,325
|
496,187
|
426,838 |
| Financial expenses |
392
|
157
|
3,920 |
| Earnings before taxes |
29,601
|
23,046
|
20,600 |
| EBITDA |
33,750
|
26,346
|
28,592 |
| Total assets |
190,214
|
228,958
|
204,092 |
| Current assets |
174,767
|
216,688
|
191,669 |
| Current liabilities |
104,587
|
162,827
|
133,214 |
| Equity capital |
85,626
|
66,131
|
48,583 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
109
|
102
|
98 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.0%
|
28.9%
|
23.8% |
| Turnover per employee |
5,186
|
4,865
|
4,355 |
| Profit as a percentage of turnover |
5.2%
|
4.6%
|
4.8% |
| Return on assets (ROA) |
15.8%
|
10.1%
|
12.0% |
| Current ratio |
167.1%
|
133.1%
|
143.9% |
| Return on equity (ROE) |
34.6%
|
34.8%
|
42.4% |
| Change turnover |
85,550
|
67,151
|
88,085 |
| Change turnover % |
18%
|
16%
|
26% |
| Chg. No. of employees |
7
|
4
|
11 |
| Chg. No. of employees % |
7%
|
4%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.